Literature DB >> 15661974

Chronic lymphocytic inflammation specifies the organ tropism of prions.

Mathias Heikenwalder1, Nicolas Zeller, Harald Seeger, Marco Prinz, Peter-Christian Klöhn, Petra Schwarz, Nancy H Ruddle, Charles Weissmann, Adriano Aguzzi.   

Abstract

Prions typically accumulate in nervous and lymphoid tissues. Because proinflammatory cytokines and immune cells are required for lymphoid prion replication, we tested whether inflammatory conditions affect prion pathogenesis. We administered prions to mice with five inflammatory diseases of the kidney, pancreas, or liver. In all cases, chronic lymphocytic inflammation enabled prion accumulation in otherwise prion-free organs. Inflammatory foci consistently correlated with lymphotoxin up-regulation and ectopic induction of FDC-M1+ cells expressing the normal cellular prion protein PrPC. By contrast, inflamed organs of mice lacking lymphotoxin-alpha or its receptor did not accumulate the abnormal isoform PrPSc, nor did they display infectivity upon prion inoculation. By expanding the tissue distribution of prions, chronic inflammatory conditions may act as modifiers of natural and iatrogenic prion transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661974     DOI: 10.1126/science.1106460

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  69 in total

1.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

2.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  PrPSc in salivary glands of scrapie-affected sheep.

Authors:  Marta Vascellari; Romolo Nonno; Franco Mutinelli; Michela Bigolaro; Michele Angelo Di Bari; Erica Melchiotti; Stefano Marcon; Claudia D'Agostino; Gabriele Vaccari; Michela Conte; Luigi De Grossi; Francesca Rosone; Francesco Giordani; Umberto Agrimi
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

Review 4.  Chronic wasting disease.

Authors:  Christina J Sigurdson; Adriano Aguzzi
Journal:  Biochim Biophys Acta       Date:  2006-10-18

5.  Alteration of B-cell subsets enhances neuroinvasion in mouse scrapie infection.

Authors:  Christine von Poser-Klein; Eckhard Flechsig; Tanja Hoffmann; Petra Schwarz; Harry Harms; Raymond Bujdoso; Adriano Aguzzi; Michael A Klein
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

6.  Lymphoid neogenesis and immune infiltration in aged liver.

Authors:  Pallavi Singh; Zeynep Z Coskun; Catriona Goode; Adam Dean; LuAnn Thompson-Snipes; Gretchen Darlington
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 7.  Aerosols: an underestimated vehicle for transmission of prion diseases?

Authors:  Lothar Stitz; Adriano Aguzzi
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

8.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

9.  Excretion of transmissible spongiform encephalopathy infectivity in urine.

Authors:  Luisa Gregori; Gabor G Kovacs; Irina Alexeeva; Herbert Budka; Robert G Rohwer
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

10.  The comprehensive native interactome of a fully functional tagged prion protein.

Authors:  Dorothea Rutishauser; Kirsten D Mertz; Rita Moos; Erich Brunner; Thomas Rülicke; Anna Maria Calella; Adriano Aguzzi
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.